This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Kosterlitz Centre for Therapeutics, Institute of Medical Sciences and J. Mallard Scottish PET Centre, University of Aberdeen, Foresterhill, Scotland, UK
E-mail: m.zanda@abdn.ac.uk
b
Precision Medicine, Pfizer WRD, Groton, USA
Chem. Commun., 2013,49, 792-794
DOI:
10.1039/C2CC38443D
Received
18 Jul 2012,
Accepted
04 Dec 2012
First published online
04 Dec 2012
Three fluoro-barbiturates were synthesised, showing in vivo sedative efficacy. One of them, [18F]1a, was synthesised in radiofluorinated form. PET/CT Imaging with [18F]1a identified β-amyloid over-expressing transgenic mice (βA mice) compared to wild type and tau lines. The fluorescent barbiturate 9 was able to label βA plaques in brain sections of βA mice, and co-localise with a fluorescent Zn(II) indicator.
Fetching data from CrossRef. This may take some time to load.